Finerenone for chronic kidney disease in type 2 diabetes

Description

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Rupert Hinds

Dr Rupert Hinds

Infant Allergy Cases

A/Prof Samantha Hocking

A/Prof Samantha Hocking

New Diagnostic Criteria for Obesity

Prof Andrew Sindone

Prof Andrew Sindone

How to Use the NT-proBNP Test in General Practice

Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

Fatal Arrhythmias – The Patterns GPs Don’t Want to Miss

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Sunil Badve

expert

Prof Sunil Badve

Nephrologist; Program Lead, Cardiometabolic Trials, Renal and Metabolic Program, The George Institute for Global Health; Senior Staff Specialist Nephrologist, St George Hospital

Date published: 21 February 2024